• Published on: May 22, 2021
  • 3 minute read
  • By: Dr Rajan Choudhary

COVID Associated Black Fungus: Succumbing To Black Fungus !

  • WhatsApp share link icon
  • copy & share link icon
  • twitter share link icon
  • facebook share link icon

COVID associated Black Fungus: What you need to know

As COVID spreads across India, there has been an increase in reports of associated infection with a black fungus occurring in some patients. It affects the nose, mouth, eyes, and lungs, and can be fatal. This is an infection we need to be educated on, and early recognition of it can be life-saving. Today we will talk about Mucormycosis, the black fungus responsible for these infections, and what you should do to prevent or recognize an infection.

If you want to learn how to recognize the infection, go down to the INFECTION section of the article.

FUNGUS

When our body gets infected by a bacteria or virus, the signs and symptoms are often recognized early because bacteria and viruses are aggressive, with toxins and mechanisms designed to cause harm to our body and cause easily recognizable symptoms. Fungi on the other hand are slow-growing, and usually, our bodies can fight usually fight these infections before they become a problem. We breathe in fungal spores all the time, especially when outside, in the garden, or in fields, and they cause no harm.

Mucormycosis, the responsible fungus, is found in soil, and decaying fruits and vegetables. It can enter our body by inhalation, by eating foods infected with it, or by direct contact with an open wound, thereby entering our blood. It can be found inside the nose of healthy people, causing no problems or disease. Before the COVID pandemic, infection by mucormycosis was up to 80 times more prevalent in India than in other developed countries, though still rare.

IMMUNOSUPPRESSION

Looking at case reports of patients infected with mucormycosis shows a common theme. Immunocompromised patients are at much higher risk of infection by the fungus and are more likely to have severe disease. This includes patients with diabetes, poorly controlled diabetes, patients taking steroids, organ transplant patients (who are usually on immunosuppressive medications to prevent rejection), those with blood cancer (leukemia/lymphoma, reducing your blood immunity).

Diabetes (especially poorly controlled diabetes) is a major problem in these cases, as diabetes is fairly common in India, can lay unrecognized, and if not controlled or treated appropriately the rising blood sugar levels can damage your arteries, nerves, and significantly lower your immunity. Any infection in diabetic patients can be more difficult to treat and spread more quickly, and this is made worse by COVID-19.

COVID causes widespread inflammation throughout the body, especially the lungs, and the resulting damage causes difficulty breathing and death by respiratory failure. Steroids are currently our best way to treat COVID, by suppressing the body’s immune system and preventing lung damage. Unfortunately, this also allows mucormycosis spores inhaled by COVID patients to infect the now vulnerable, damaged airway, lungs, and sinuses, and start spreading. The body’s response to the infection is dampened by the steroids, and in those with diabetes, it is hindered further.

INFECTION

The black fungus usually spreads in the nose and sinuses of the skull, as it prefers a warm, humid environment. From here it can spread into the eyes and in rare cases the brain.

Recognize the symptoms of the fungus, and be very suspicious in patients with diabetes or those who have had high doses of steroids.

- Facial swelling on one side

- Nose or sinus congestion

- Pain in the sinuses, around the nose, and eyes

- Black mold growing around the nose or mouth

- Fever, headache

When it infects the lungs it can cause symptoms such as cough, shortness of breath, or chest pain. Unfortunately, this can be difficult to separate from symptoms of COVID infection.

If you suspect you or someone you know has these symptoms, and they have the risk factors of immunosuppression or diabetes, you should visit a doctor early. Mucormycosis has a high mortality rate, and a delay in diagnosis by even a week can double it. Your doctor will take swab samples from your nose and look for signs of the fungus under a microscope. Blood tests and scans are also helpful in identifying the fungal infection.

TREATMENT AND PREVENTION

Treatment of mucormycosis requires IV antifungals such as Amphotericin B and may involve surgery to remove the infected areas and prevent further spread. This can include surgery in and around the nose, sinuses, and in rare cases even the eyes. This all depends on the extent of the fungal infection.

Prevention is key in these cases. Simple measures such as wearing a mask to reduce inhalation of spores can minimize infection, especially in the vulnerable, though it may not prevent it if they already had spores present in their nose and sinuses. Glucose tests to look for diabetes, and strict control of diabetes will improve your chances significantly. Keeping your blood sugar levels within the normal range is very important, so if you are diabetic now is the time to stick to your diabetic diet and medications.

Finally, we need to be careful when using immunosuppressive medications to treat COVID, and determining which patients should receive steroids (dexamethasone, prednisolone) and other drugs such as tocilizumab. If you are young and healthy, or you have a milder infection of COVID-19, it may be better for you to not take steroids early. Those with more serious COVID-19 infections may need steroids to survive, and in these cases frequent checks for mucormycosis infection is advisable.

The rise in this rare fungal disease in patients with COVID-19 presents a problem, as we do not have much literature to base our recommendations on, the disease is slow-growing and can be difficult to treat. But as always, understanding the disease process for black fungus and knowing its symptoms is important, as is informing your family and friends about this disease.

Read Blog
Guillain-Barre syndrome - Symptoms and causes

Guillain-Barre syndrome - Symptoms and causes

Guillain-Barré syndrome (GBS) is a rare but serious neurological condition in which the body’s immune system mistakenly attacks the peripheral nervous system. This condition can lead to muscle weakness, numbness, and even paralysis in severe cases. Understanding Guillain-Barré syndrome symptoms, causes, and treatment options is crucial for early detection and effective management.

Guillain-Barré Syndrome Symptoms

The symptoms of Guillain-Barré syndrome typically begin with mild sensations of tingling or numbness in the hands and feet. These early signs of Guillain-Barré syndrome may quickly progress to more severe issues, including:

  • Muscle Weakness: Starting in the legs and spreading to the upper body, this weakness can become so severe that mobility is significantly impaired.

  • Reflex Loss: Deep tendon reflexes, such as the knee-jerk response, are often diminished or absent.

  • Pain: Many individuals experience sharp or cramping pain, particularly in the lower back.

  • Difficulty with Eye or Facial Movements: Symptoms may include difficulty speaking, chewing, or swallowing.

  • Respiratory Problems: In some cases, Guillain-Barré syndrome and respiratory failure become significant concerns, necessitating immediate medical intervention.

  • Autonomic Dysfunction: Irregular heart rhythms, blood pressure fluctuations, and other involuntary functions can be affected.

Guillain-Barré Syndrome Causes

The exact causes of Guillain-Barré syndrome are not fully understood. However, it is widely believed that the syndrome is triggered by an overactive immune response to an infection or other environmental factors. Common Guillain-Barré syndrome causes and risk factors include:

  • Viral Infections: Conditions such as influenza, Zika virus, and Epstein-Barr virus have been associated with GBS.

  • Bacterial Infections: Campylobacter jejuni, a bacterium often linked to food poisoning, is a common trigger.

  • Vaccinations: Although extremely rare, certain vaccines have been linked to GBS.

  • Surgical Procedures: Some individuals may develop Guillain-Barré syndrome following surgery.

  • Other Risk Factors: A history of autoimmune disorders or genetic predispositions may increase the risk.

Guillain-Barré Syndrome Progression Stages

Guillain-Barré syndrome progression stages typically unfold in three distinct phases:

  1. Initial Stage: Lasting 1-4 weeks, this stage includes the rapid onset of Guillain-Barré syndrome symptoms such as weakness and numbness.

  2. Plateau Stage: Symptoms stabilize but remain severe. This stage can last several weeks.

  3. Recovery Stage: Gradual improvement begins, although Guillain-Barré syndrome recovery time can vary significantly between individuals, often taking weeks to months.

Guillain-Barré Syndrome Diagnosis

Diagnosing Guillain-Barré syndrome requires a thorough clinical evaluation. Physicians rely on specific Guillain-Barré syndrome diagnosis criteria, which include:

  • Patient History: Recent infections or medical procedures may provide crucial clues.

  • Neurological Examination: Reflexes, muscle strength, and sensory responses are assessed.

  • Electrodiagnostic Tests: Nerve conduction studies (NCS) and electromyography (EMG) help identify nerve damage.

  • Lumbar Puncture: Testing cerebrospinal fluid (CSF) can reveal elevated protein levels, a hallmark of GBS.

Early diagnosis is essential for effective treatment and to prevent complications like Guillain-Barré syndrome and respiratory failure.

Guillain-Barré Syndrome Treatment

Treatment for Guillain-Barré syndrome focuses on managing symptoms and speeding up recovery. The primary Guillain-Barré syndrome treatment options include:

  • Plasma Exchange (Plasmapheresis): This procedure removes harmful antibodies from the blood.

  • Intravenous Immunoglobulin (IVIG): High-dose immunoglobulin therapy helps neutralize the antibodies attacking the nervous system.

  • Supportive Care: Ventilatory support may be needed in severe cases, along with physical therapy to aid rehabilitation.

Guillain-Barré Syndrome Prognosis

The prognosis for Guillain-Barré syndrome varies depending on the severity of the condition and the timeliness of treatment. While most individuals recover fully, Guillain-Barré syndrome prognosis can include long-term complications such as:

  • Persistent Weakness: Some patients may experience lingering muscle weakness.

  • Nerve Damage: Chronic nerve pain or numbness can occur in rare cases.

  • Recurrence: Although uncommon, some individuals may develop Guillain-Barré syndrome again.

Guillain-Barré Syndrome Recovery Time

Guillain-Barré syndrome recovery time can range from a few weeks to several months. Factors that influence recovery include:

  • Age: Younger individuals generally recover faster.

  • Severity: Severe cases with extensive nerve damage may take longer to heal.

  • Timely Treatment: Early intervention is key to minimizing long-term effects and shortening recovery time.

Conclusion

Guillain-Barré syndrome is a challenging condition that requires early recognition and prompt treatment. By understanding the symptoms, causes, and treatment options, individuals can better manage this syndrome and improve their outcomes. If you or a loved one suspect Guillain-Barré syndrome, consult a healthcare professional immediately. Early diagnosis and treatment are critical for a full recovery.

See all

Live Doctor consultation
Live Doctor Chat

Download Our App & Get Consultation from anywhere.

App Download
call icon for mobile number calling and whatsapp at secondmedic